Spinnaker Biosciences
Solana Beach, US · Delaware corporation
Spinnaker Biosciences develops porous silicon, porous silicon oxide, and silicon/polymer composite materials engineered as controlled-release drug delivery vehicles. Its biocompatible, biodegradable particles provide protected storage and sustained release of therapeutic payloads, with surface chemistry that supports targeting agents such as peptides and antibodies.
Founders & leadership
MF
Malcolm FinlaysonExecutive
VT
Virgil ThompsonExecutive
MS
Michael SailorNamed on SEC filing
Board
WF
William FreemanBoard director
Reported raises · per SEC filings
Form D private placements$1.6M disclosed across 2 rounds · 2014–2024
▶$666.8KraisedDec 2024 · 1 investors · Other Health CareRule 506(b)
▶$666.8KraisedDec 2024 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Malcolm FinlaysonExecutive Officer, Director
- Michael SailorDirector
- William FreemanDirector
- Offering amount
- $1.3M
- Amount sold
- $666.8K
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$900KraisedMay 2015 · 2 investors · Other Health CareRule 506(b)
▶$900KraisedMay 2015 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Virgil ThompsonExecutive Officer, Director
- Michael SailorDirector
- William FreemanDirector
- Offering amount
- $3M
- Amount sold
- $900K
- First sale
- Oct 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Spinnaker Biosciences do?
- Spinnaker Biosciences develops porous silicon, porous silicon oxide, and silicon/polymer composite materials engineered as controlled-release drug delivery vehicles. Its biocompatible, biodegradable particles provide protected storage and sustained release of therapeutic payloads, with surface chemistry that supports targeting agents such as peptides and antibodies.
- How much funding has Spinnaker Biosciences raised?
- Spinnaker Biosciences has disclosed $1.6M raised across 2 rounds.
- Where is Spinnaker Biosciences headquartered?
- Spinnaker Biosciences is headquartered in Solana Beach, US.